The PARKIN ubiquitin ligase (also known as PARK2) and its regulatory kinase PINK1 (also known as PARK6), often mutated in familial early-onset Parkinson's disease, have central roles in mitochondrial homeostasis and mitophagy 1-3 . Whereas PARKIN is recruited to the mitochondrial outer membrane (MOM) upon depolarization via PINK1 action and can ubiquitylate porin, mitofusin and Miro proteins on the MOM 1,4-11 , the full repertoire of PARKIN substrates-the PARKIN-dependent ubiquitylomeremains poorly defined. Here we use quantitative diGly capture proteomics (diGly) 12,13 to elucidate the ubiquitylation site specificity and topology of PARKIN-dependent target modification in response to mitochondrial depolarization. Hundreds of dynamically regulated ubiquitylation sites in dozens of proteins were identified, with strong enrichment for MOM proteins, indicating that PARKIN dramatically alters the ubiquitylation status of the mitochondrial proteome. Using complementary interaction proteomics, we found depolarization-dependent PARKIN association with numerous MOM targets, autophagy receptors, and the proteasome. Mutation of the PARKIN active site residue C431, which has been found mutated in Parkinson's disease patients, largely disrupts these associations. Structural and topological analysis revealed extensive conservation of PARKIN-dependent ubiquitylation sites on cytoplasmic domains in vertebrate and Drosophila melanogaster MOM proteins. These studies provide a resource for understanding how the PINK1-PARKIN pathway re-sculpts the proteome to support mitochondrial homeostasis.
The PARKIN ubiquitin ligase (also known as PARK2) and its regulatory kinase PINK1 (also known as PARK6), often mutated in familial early-onset Parkinson's disease, have central roles in mitochondrial homeostasis and mitophagy [1] [2] [3] . Whereas PARKIN is recruited to the mitochondrial outer membrane (MOM) upon depolarization via PINK1 action and can ubiquitylate porin, mitofusin and Miro proteins on the MOM 1, [4] [5] [6] [7] [8] [9] [10] [11] , the full repertoire of PARKIN substrates-the PARKIN-dependent ubiquitylomeremains poorly defined. Here we use quantitative diGly capture proteomics (diGly) 12, 13 to elucidate the ubiquitylation site specificity and topology of PARKIN-dependent target modification in response to mitochondrial depolarization. Hundreds of dynamically regulated ubiquitylation sites in dozens of proteins were identified, with strong enrichment for MOM proteins, indicating that PARKIN dramatically alters the ubiquitylation status of the mitochondrial proteome. Using complementary interaction proteomics, we found depolarization-dependent PARKIN association with numerous MOM targets, autophagy receptors, and the proteasome. Mutation of the PARKIN active site residue C431, which has been found mutated in Parkinson's disease patients, largely disrupts these associations. Structural and topological analysis revealed extensive conservation of PARKIN-dependent ubiquitylation sites on cytoplasmic domains in vertebrate and Drosophila melanogaster MOM proteins. These studies provide a resource for understanding how the PINK1-PARKIN pathway re-sculpts the proteome to support mitochondrial homeostasis.
PARKIN, a RING-HECT hybrid E3 ubiquitin ligase 14 , is recruited to the MOM in cancer cell lines, mouse embryo fibroblasts (MEFs) and primary neurons to promote mitophagy in response to mitochondrial depolarization 1, 2, 15, 16 . This process requires PINK1, which binds the MOM translocase (TOMM) complex and phosphorylates PARKIN on multiple residues to promote MOM localization and ligase activation [17] [18] [19] [20] . The best understood PARKIN substrates are MFN1/2 and RHOT1/2 (MIRO in Drosophila), MOM-tethered GTPases whose PARKINdependent proteasomal turnover alters fission-fusion cycles and microtubule-dependent trafficking of mitochondria, respectively 1, [5] [6] [7] [8] 10, 11 . The MOM porin proteins VDAC1/2/3 are also ubiquitylated by PARKIN, and are required for PARKIN localization on mitochondria through a poorly understood mechanism 9, 21 . Proteomic studies of purified mitochondria have also identified additional proteins whose abundance is either decreased or increased upon PARKIN activation or mitochondrial depolarization 1, 4 , but precisely how these proteins are regulated and the extent to which ubiquitin is involved is unclear. Consequently, we do not have a comprehensive understanding of cellular PARKIN targets, which is critical for elucidating how PARKIN promotes mitochondrial homeostasis. Moreover, for the vast majority of E3 ubiquitin ligases, including PARKIN, the extent to which ubiquitin transfer is site specific and signal dependent is largely unknown, and a global understanding of site specificity across a wide range of substrates is lacking for any E3. Such information is necessary for decoding the cellular and molecular topology of E3 function and for defining how the ubiquitin system re-sculpts the proteome.
We set out to systematically identify cellular PARKIN-dependent ubiquitylation targets and the dynamics of modification in a sitespecific manner using quantitative diGly (QdiGly) proteomics. QdiGly merges antibody-based capture of 'diGly remnant'-containing peptides (marking ubiquitylated proteins after trypsinolysis) and stable isotopic labelling with amino acids in culture (SILAC) to identify ubiquitylation sites that are dynamically induced, in this case, upon mitochondrial depolarization 12, 13 . To overcome inherent stochastic sampling for low-abundance diGly peptides (see Supplementary  Fig. 1a , b) 12, 13 , we performed 73 control and QdiGly profiling experiments in four cell lines with and without elevated PARKIN levels (,tenfold) ( Supplementary Fig. 2a ) in a three-tiered manner, varying the length of depolarization with carbonyl cyanide m-chlorophenyl hydrazone (CCCP) ( Fig. 1a and Supplementary Table 1 ). In some cases, protein turnover was blocked by proteasome inhibition with bortezomib (Btz) or autophagy inhibition with bafilomycin A (BafA) ( Supplementary Table 1 ). Elevated PARKIN levels were used to increase the likelihood of capturing signal-dependent and mechanistically relevant ubiquitylation events that would otherwise be below the level of detection due to low stoichiometry or abundance.
Using HCT116 cells expressing a haemagglutinin-derived epitope tag (HA)-fused with PARKIN (HCT116 PARKIN , Tier 1), we performed 34 control and QdiGly experiments ( Supplementary Table 1 ), quantifying 4,772 non-redundant ubiquitylation sites in 1,654 proteins ( Fig. 1a, b ). In 18 of these experiments using Btz or CCCP/Btz for 1 h, we identified 443 diGly sites (261 proteins) with log 2 (heavy:light (H:L)) ratios $ 1.0 (twofold change) in at least one experiment ( Fig. 1b , c, Supplementary Fig. 2a -c, Supplementary Tables 1, 2), with a Pearson's correlation of 0.69 for two representative experiments ( Supplementary Fig. 2e ). Sixteen additional Tier 1 experiments with depolarization times up to 10 h identified 537 non-redundant diGly sites (304 proteins), including 192 diGly sites (138 proteins) also identified at 1 h ( Supplementary Fig. 2d ). Comparison of log 2 (H:L) ratios for 48 Tier 1 sites in 36 proteins at 1 and 8 h post CCCP treatment from parallel experiments revealed persistent or increased ubiquitylation for 34 sites when proteasome activity is blocked ( Supplementary Fig. 2f ).
To systematically determine PARKIN dependence and compare targets in distinct cell lines, we performed 6 QdiGly experiments in HeLa versus HeLa PARKIN cells (Tier 2) with CCCP/Btz (1 h) and reverse SILAC labelling ( Fig. 1a , Supplementary Tables 1, 2). As expected 4-7 , CCCP-dependent MFN2 poly-ubiquitylation in HeLa cells required PARKIN expression ( Supplementary Fig. 2a ). We identified 582 PARKIN-dependent diGly peptides (303 proteins) ( Fig. 1b) , with a Pearson's correlation of 0.88 for duplicate samples (Supplementary Fig. 2e ) and significant overlap across biological triplicates ( Fig. 1d ). Importantly, 165 diGly sites (99 proteins) were common to Tiers 1 and 2 with 1 h of depolarization ( Fig. 1e ). This increased to 191 sites (144 proteins) when all Tier1 and Tier 2 data were compared (Supplementary Table 2 ). We refer to the overlapping set of ubiquitylation sites with 1 h of depolarization and their associated proteins as Class 1 candidate PARKIN-dependent targets, whereas proteins found in both cell lines but with different sites of ubiquitylation are referred to as Class 2 (Supplementary Table 2 ). Whereas a twofold increase in H:L ratio was used as a threshold for regulated ubiquitylation, many diGly sites were induced 30-60-fold upon depolarization ( Fig. 1f , Supplementary Table 2 ), indicating highly dynamic target modification via PARKIN.
Class 1 targets were enriched in mitochondrial proteins (P , 1.76 3 10 217 ), although numerous cytoplasmic proteins were also identified ( Fig. 2 , Supplementary Fig. 2i ). In total, 60 Class 1 and 2 targets were linked with mitochondria or endoplasmic reticulum-type membranes, including 36 MOM proteins. Candidate cytoplasmic targets included proteasome subunits, the VCP/p97 ATPase, and proposed autophagy adaptors (SQSTM1, CALCOCO2 (also known as NDP52), and TAX1BP1).
We next performed 22 control and QdiGly profiling experiments using HCT116 or neuronal SH-SY5Y cells (Tier 3, Fig. 1a , b, Supplementary Tables 1, 2), which show primarily mono-ubiquitylated forms of MFN2 ubiquitylation upon depolarization, apparently due to low levels of endogenous PARKIN ( Supplementary Fig. 2a ). Cumulatively, 838 diGly sites (391 proteins) in HCT116 and 337 diGly sites (235 proteins) in SH-SY5Y had log 2 (H:L) $ 1.0 ( Fig. 1b) , with extensive overlap across Tier 1 and 2 data sets ( Supplementary Fig. 2g ) and biological triplicates in SH-SY5Y (1 h/CCCP) ( Supplementary  Fig. 2h ). Fifteen sites in 12 Class 1 or 2 targets were found in both cell lines, and 29 and 27 CCCP-dependent diGly sites in 27 and 17 Class 1 or 2 proteins were detected in SH-SY5Y or HCT116 cells, respectively ( Fig. 2 , Supplementary Tables 1, 2) . Additionally, 124 Tier 3 sites were identified in 29 Class 1 or 2 proteins that were distinct from Class 1 sites. Thus, many PARKIN-dependent diGly targets were confirmed at endogenous PARKIN levels. Ubiquitylation of several candidate substrates was demonstrated by immunoblotting, and ubiquitylation was reduced upon small-interfering RNA (siRNA)-mediated depletion of PARKIN for several targets tested ( Supplementary Fig. 3a-d ).
To complement QdiGly proteomics, we used anti-HA affinity purification-mass spectrometry (AP-MS) 22 to identify depolarizationdependent high-confidence candidate HA-PARKIN-interacting proteins (HCIPs) in duplicate experiments in 293T PARKIN cells ( Fig. 3a , Supplementary Fig. 4a , Supplementary Table 3) , with further validation in HeLa PARKIN cells ( Supplementary Fig. 4b , Supplementary Table 4 ) (see Methods). Because PARKIN action is dynamic, we examined several time points (1, 4 or 8 h) after depolarization in the presence or absence of Btz or BafA. To allow a semiquantitative assessment of interactions, we compared bait-normalized average assembled peptide spectral matches (APSMs) for proteins that were HCIPs under at least one condition examined unless otherwise noted ( Fig. 3a , Supplementary Fig. 4a , Supplementary Tables 3, 4 ). Without depolarization, no HCIPs were common to both wild-type PARKIN biological duplicates, consistent with PARKIN auto-inhibition before activation 23 (Fig. 3a , Supplementary Text). Remarkably, upon depolarization, four classes of HCIPs were identified in at least one condition examined ( Fig. 3a, b ): (1) 20 MOM proteins, including MFN1/2, RHOT1/2 and VDACs, HK1/2, the fission protein FIS1 and its interacting protein TBC1D15, and the translocase components TOMM20 and TOMM70; (2) the autophagy adaptors SQSTM1 (also known as p62), CALCOCO2 and TAX1BP1; (3) subunits of the catalytic and regulatory particles of the proteasome; and (4) the VCP (also known as p97) ATPase implicated in MFN1 turnover 7 . Nineteen of the 26 mitochondrial and autophagy proteins and 39 of 40 proteasome subunits found in 293T cells were also identified in at least one condition examined in HeLa cells ( Fig. 3b, Supplementary Fig. 4b ). Depolarizationdependent interaction of Flag-PARKIN with selected endogenous HCIPs was verified by anti-Flag immunoprecipitation and immunoblotting ( Supplementary Fig. 5 ). Notably, 21 of the 27 mitochondrial and autophagy receptor proteins found associated with PARKIN, as well as eight subunits of the regulatory particle of the proteasome and VCP, were also identified as Class 1 or 2 PARKIN-dependent ubiquitylation targets (Figs 2, 3b, Supplementary Table 2 ).
PARKIN activation is thought to reverse auto-inhibition by its aminoterminal ubiquitin-like domain (UBL), which has been proposed to 
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sterically hinder ubiquitin-conjugating (E2) enzyme interaction with the catalytic centre 20, 23 . We explored the role of these regions in MOM recruitment, MFN2 ubiquitylation, substrate binding and proteasome association by using five mutants ( Supplementary Fig. 6a ): (1) DUBL, lacking the UBL domain (residues 1-80), (2) K27/48R, which blocks ubiquitylation of two regulated diGly sites in the UBL (Fig. 2) , (3) S65A and S65E, which block PINK1-dependent phosphorylation of the UBL domain implicated in PARKIN activation in vitro 18 , and (4) C431S, removing the active site Cys in RING2. The Parkinson's disease patient mutation PARKIN(C431F) fails to localize to mitochondria in response to depolarization 15, 20 . Consistent with this, PARKIN(C431S) failed to localize to mitochondria, efficiently poly-ubiquitylate MFN2, or interact robustly with MOM substrates in response to depolarization ( Fig. 3a, Supplementary Fig. 6a-d) . In contrast, K27/K48R, S65A and S65E mutants showed near wild-type activity for localization, MFN2 ubiquitylation and interaction with MOM proteins at 1 h post depolarization ( Fig. 3a, Supplementary Fig. 6a-d , Supplementary  Tables 3, 6 ), although we cannot rule out a kinetic effect of these mutations. PARKIN(DUBL) displayed readily detectable association with MOM substrates in the absence of depolarization, consistent with some loss of auto-inhibition 22 , but nevertheless showed enhanced substrate association upon depolarization, indicating residual PINK1 dependence despite the absence of the UBL and S65. However, MFN2 ubiquitylation was reduced compared with wild-type PARKIN, suggesting reduced ubiquitylation activity. PARKIN(DUBL) also lacked a robust increase in proteasomal binding (Fig. 3a) .
Our data indicate that PARKIN interacts with and promotes the site-specific ubiquitylation of numerous mitochondrial and cytoplasmic proteins, thereby extending previous studies examining abundance of mitochondrially enriched proteins 1, 4 . To place candidate PARKIN-dependent ubiquitination targets into a structural and functional framework, we have created an interactive resource that integrates dynamic ubiquitylation data with available structural information ( Supplementary Fig. 7b -e and Methods). We explored the spatial relationship between protein localization, structure and conservation for 90 Class 1 sites on 36 candidate PARKIN substrates ( Fig. 4a-d , Supplementary Fig. 7a , Supplementary Table 5 ). We found that 90% of ubiquitylated lysine residues are conserved in mouse (Mus musculus), 78% in zebrafish (Danio rerio), and 51% in the 29 conserved orthologues in D. melanogaster, which harbours an active PARKIN-PINK1 pathway 6 . Moreover, 38% of sites were conserved in all three species, and 22 of 36 proteins have at least one site conserved from human to D. melanogaster ( Fig. 4a-d, Supplementary Fig. 7a ). DiGly sites were observed on multiple structural elements (a-helices, b-sheets and loops) and no obvious sequence motif was identified by MOTIFX, indicating that PARKIN specificity is driven primarily by substrate recruitment and/or proximity rather than specific target sequences.
Of the 17 MOM targets whose structures or membrane orientations are defined, all identified ubiquitylation sites are presented on the cytoplasmic surface ( Fig. 4c, d) , consistent with the idea that PARKIN re-sculpts the MOM proteome via its cytoplasmic recruitment. Fifty-nine percent of Class 1 and 2 targets had one or two sites of ubiquitylation, whereas 41% of targets had 3-15 sites that were PARKIN-dependent on the basis of Tier 2 analysis ( Supplementary  Fig. 7f ). Of the eight Class 1 and Class 2 sites identified in MFN1, all but two are located in helical motifs flanking the two carboxy-terminal membrane-spanning regions, indicating localized ubiquitylation ( Fig. 2  and Fig. 4d ). We detected 14 Class 1 and 2 sites in HK1, but unlike MFN1, these sites were comparatively delocalized across both globular domains in HK1 (Fig. 4c) . Similarly, TOMM70 was decorated extensively over its 10 cytoplasmic TPR motifs (Figs 2, 4d ). Although we cannot exclude the possibility that some ubiquitylation events occur downstream of PARKIN activation, the fact that we find many of the targets as PARKIN-interacting proteins (Fig. 3b) is consistent with direct ubiquitylation (see Supplementary Text ). An understanding of how PARKIN ubiquitylates topologically diverse proteins and domains within proteins requires further study but will be facilitated by the sitespecificity data reported here.
PARKIN seems to promote rapid turnover of some targets but not others. In total, 12 of the Class 1 and 2 proteins identified here (see Fig. 2 ), like MFN1/2 and RHOT1/2 1, 4, 7, 10, 11 , probably undergo proteasomal turnover, including C1QBP1 ( Supplementary Fig. 3c, d) , FIS1 and CISD1, as their total levels are also decreased upon PARKIN activation 1, 4 . In contrast, previous studies 4 have identified 50 preferentially cytoplasmic proteins or protein complexes that are enriched in mitochondria in response to depolarization. Consistent with this, we identified 11 of these proteins or components of protein complexes as Class 1 or 2 targets ( Fig. 2 and Supplementary Fig. 7g ), possibly reflecting an under-appreciated dynamic recruitment process affecting mitochondrial homeostasis. These include the autophagy adaptor p62, previously linked with mitochondrial clustering after damage 24 , as well as TBC1D15 and DNML1, which are known to interact with FIS1 to regulate fission-fusion cycles 25 . In addition to p62, we also identified candidate autophagy receptors, CALCOCO2 and TAX1BP1, which are ubiquitylated upon depolarization and associate with PARKIN in the presence of BafA (Figs 2, 3 ). Because CALCOCO2 has been shown to target bacteria for autophagy 26 , it is an attractive candidate for involvement in mitophagy. We speculate that these related autophagy adaptor proteins may be dynamically recruited to the MOM and may link the depolarization response to the recruitment of autophagy machinery. Additionally, it is possible that additional cytoplasmic proteins identified here as PARKIN-dependent targets are transiently recruited to mitochondria but below the level of detection in previous studies. It is also likely that ubiquitylation of PARKIN targets alters their enzymatic properties or functions before their turnover by the proteasome or autophagy. Potential PARKIN-regulated functions include: (1) fission-fusion cycles (FIS1, TBC1D15), (2) small molecule transport (VDACs), (3) apoptosis (FKBP8, MCL1, BAX), (4) Supplementary Table 5 ). a, Legend for colour-coded circles that indicate the conservation of Lys at homologous positions in M. musculus, D. rerio and D. melanogaster (Supplementary Table 5 ). For structures, regulated sites are shown in red space-filled models. b, Cytoplasmic proteins. RPN10, red circle. c, MOM proteins with structures. d, MOM proteins without structures.
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iron-sulphur shuttling (CISD1), (5) protein translocation (TOMM70) or (6) proteasome assembly or activity (PSMC subunits) (see Supplementary Text) 25, 27 . This work provides systematic target identification and ubiquitylation site-specificity for PARKIN, thereby revealing the diversity and complexity of PARKIN function on the MOM and in the cytoplasm. This resource will enable the development of methods that detect specific diGly sites in PARKIN targets in situ, thus enabling a deeper understanding of how PARKIN controls mitochondrial homeostasis in tissues relevant to Parkinson's disease.
METHODS SUMMARY
Cells were grown in Lys(K)-free DMEM/dialysed fetal bovine serum, with light (K0) or heavy (K8) Lys (50 mg ml 21 ) 12 , and treated with Btz (1 mM), CCCP (10 mM), and/or BafA (50 nM). Mixed cells were lysed in 8 M urea, 75 mM NaCl, 50 mM Tris HCl (pH 8.2), and tryptic/LysC peptides immunoprecipitated with anti-diGly-Protein A (Cell Signaling Technologies) (1 h, 4 uC), typically with 2-4 sequential immunoprecipitations (Supplementary Table 1 ) 12 . Peptides and ubiquitylation sites were identified by liquid chromatography-tandem mass spectrometry (see Methods) 12 . Extracted ion chromatograms were used for quantification and signal-to-noise measurements 12 . Interaction proteomics used 293T or HeLa cells stably expressing HA-Flag-PARKIN (or mutants) and CompPASS to identify HCIPs 22 .
